Literature DB >> 15595250

Cerebral vein and sinus thrombosis in Isfahan-Iran: a changing profile.

Mohammad Saadatnia1, Seyyed Ali Mousavi, Sassan Haghighi, Ashraf Aminorroaya.   

Abstract

OBJECTIVES: This study was performed to investigate the clinical presentation and predisposing factors for cerebral vein and sinus thrombosis (CVST) in Isfahan, Iran.
METHODS: Data from the records of all patients with CVST referred to the largest tertiary-care hospital of Isfahan during a five-year period (1997 to 2001) were extracted and reviewed.
RESULTS: The number of cases with CVST diagnosed annually was 6, 9, 11, 14 and 15 patients, respectively. Thirteen men and 42 women were diagnosed to have CVST with the mean age of 35.1 +/- 3.8 and 28.7 +/- 1.3 years, respectively. Headache was the most frequent complaint (95%) and 63% of patients had focal neurological symptoms, including seizure (58%). Among possible predisposing factors, oral contraceptive pill was the most prevalent one, which was used by 38.1% of affected women for a period of as short as 1-3 months. Anticardiolipin antibodies were detected in 14% of patients.
CONCLUSIONS: It seems that the annual incidence of CVST is increasing in Isfahan, perhaps due to more extensive intake of oral contraceptive pills and usage of more accurate modern diagnostic tools. The use of oral contraceptive pills was the most frequent predisposing factor; infections and postpartum factors were infrequently observed. Despite other reports from the Middle East, Behçet's disease is not a principal risk factor for CVST in Isfahani patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15595250     DOI: 10.1017/s0317167100003656

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  9 in total

1.  Cerebral venous thrombosis as an extrahepatic manifestation of acute anicteric hepatitis a infection.

Authors:  Panagiotis Zis; Elli Kontogeorgi; Dimitrios Karakalos; Despoina Pavlopoulou; Vassilios A Sevastianos
Journal:  Case Rep Neurol Med       Date:  2012-07-17

2.  Cerebral venous sinus thrombosis in iran: cumulative data, shortcomings and future directions.

Authors:  Afshin Borhani Haghighi; Nahid Ashjazadeh; Anahid Safari; Salvador Cruz-Flores
Journal:  Iran Red Crescent Med J       Date:  2012-12-06       Impact factor: 0.611

3.  A case-series study of cerebral venous thrombosis in women using short course oral contraceptive.

Authors:  Payam Khomand; Kambiz Hassanzadeh
Journal:  Iran J Neurol       Date:  2016-04-03

4.  Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis.

Authors:  Mohammad Saadatnia; Neda Naghavi; Farzad Fatehi; Mohammad Zare; Marzieh Tajmirriahi
Journal:  J Res Med Sci       Date:  2012-04       Impact factor: 1.852

5.  Cerebral venous-sinus thrombosis: a case series analysis.

Authors:  Nahid Ashjazadeh; Afshin Borhani Haghighi; Maryam Poursadeghfard; Hoseinjan Azin
Journal:  Iran J Med Sci       Date:  2011-09

6.  Anticoagulant therapy for ischemic stroke: A review of literature.

Authors:  Mohammad Mehdi Shahpouri; Seyed Mousavi; Faribourz Khorvash; Seyed Morteza Mousavi; Tahereh Hoseini
Journal:  J Res Med Sci       Date:  2012-04       Impact factor: 1.852

7.  Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study.

Authors:  Mohammad Saadatnia; Mansour Salehi; Ahmad Movahedian; Seyed Ziaeddin Samsam Shariat; Mehri Salari; Marzieh Tajmirriahi; Elham Asadimobarakeh; Rasoul Salehi; Gilda Amini; Homa Ebrahimi; Ehsan Kheradmand
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852

8.  Clinical features, risk factors, and outcome of cerebral venous thrombosis in Tehran, Iran.

Authors:  Samira Yadegari; Askar Ghorbani; S Roohollah Miri; Mohammad Abdollahi; Mohsen Rostami
Journal:  J Neurosci Rural Pract       Date:  2016 Oct-Dec

Review 9.  Seizure in cerebral venous and sinus thrombosis.

Authors:  Jafar Mehvari Habibabadi; Mohammad Saadatnia; Nasim Tabrizi
Journal:  Epilepsia Open       Date:  2018-06-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.